Tomoki Todo

Publication Activity (10 Years)

Years Active: 2021-2023
Publications (10 Years): 9

Top Topics

Herpes Simplex Virus

Signaling Pathway

Top Venues

Communications medicine

Cancer research communications

Nature medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Kazuya Fukasawa, Jiajun Lyu, Takuya Kubo, Yuki Tanaka, Akane Suzuki, Tetsuhiro Horie, Akane Tomizawa, Ryoma Osumi, Sayuki Iwahashi, Kazuya Tokumura, Misato Murata, Masaki Kobayashi, Tomoki Todo, Atsushi Hirao, Eiichi Hinoi
MEK5-ERK5 Axis Promotes Self-renewal and Tumorigenicity of Glioma Stem Cells. Cancer research communications 3 (1) (2023)
Hiroshi Fukuhara, Yuzuri Tsurumaki Sato, Jiangang Hou, Miwako Iwai, Tomoki Todo
Fusion peptide is superior to co-expressing subunits for arming oncolytic herpes virus with interleukin 12. Communications medicine 3 (1) (2023)
Hiroshi Fukuhara, Yuzuri Tsurumaki Sato, Jiangang Hou, Miwako Iwai, Tomoki Todo
Fusion peptide is superior to co-expressing subunits for arming oncolytic herpes virus with interleukin 12. Communications medicine 3 (1) (2023)
Kazuya Fukasawa, Jiajun Lyu, Takuya Kubo, Yuki Tanaka, Akane Suzuki, Tetsuhiro Horie, Akane Tomizawa, Ryoma Osumi, Sayuki Iwahashi, Kazuya Tokumura, Misato Murata, Masaki Kobayashi, Tomoki Todo, Atsushi Hirao, Eiichi Hinoi
MEK5-ERK5 Axis Promotes Self-renewal and Tumorigenicity of Glioma Stem Cells. Cancer research communications 3 (1) (2023)
Hiroshi Fukuhara, Yuzuri Tsurumaki Sato, Jiangang Hou, Miwako Iwai, Tomoki Todo
Fusion peptide is superior to co-expressing subunits for arming oncolytic herpes virus with interleukin 12. Communications medicine 3 (1) (2023)
Manami Hiraiwa, Kazuya Fukasawa, Takashi Iezaki, Hemragul Sabit, Tetsuhiro Horie, Kazuya Tokumura, Sayuki Iwahashi, Misato Murata, Masaki Kobayashi, Akane Suzuki, Gyujin Park, Katsuyuki Kaneda, Tomoki Todo, Atsushi Hirao, Mitsutoshi Nakada, Eiichi Hinoi
SMURF2 phosphorylation at Thr249 modifies glioma stemness and tumorigenicity by regulating TGF-β receptor stability. Communications biology 5 (1) (2022)
Tomoki Todo, Hirotaka Ito, Yasushi Ino, Hiroshi Ohtsu, Yasunori Ota, Junji Shibahara, Minoru Tanaka
Intratumoral oncolytic herpes virus G47∆ for residual or recurrent glioblastoma: a phase 2 trial. Nature medicine 28 (8) (2022)
Tomoki Todo, Yasushi Ino, Hiroshi Ohtsu, Junji Shibahara, Minoru Tanaka
A phase I/II study of triple-mutated oncolytic herpes virus G47∆ in patients with progressive glioblastoma. Nature communications 13 (1) (2022)
Hiroshi Fukuhara, Yuta Takeshima, Tomoki Todo
Triple-mutated oncolytic herpes virus for treating both fast- and slow-growing tumors. Cancer science 112 (8) (2021)